For the Inventor, By the Inventor

Enter inventor name

San Francisco, CA, United States of America

Lawrence M Kauvar

USPTO Granted Patents = 82 (Patent Applications = 12)

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 16)

Average Co-Inventor Count = 2.0

ph-index = 17

Forward Citations = 887(Granted Patents)

Forward Citations (Not Self Cited) = 768(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Fransico, CA (US) (1992)
Mountain View, CA (US) (2005 - 2009)
San Francisco, CA (US) (1990 - 2023)

Company Filing History:

Terrapin Technologies, Inc.

Trellis Bioscience, Inc.

Trellis Bioinformatics, Inc.

Niigata University

Trellis Rsv Holdings, Inc.

Contrafect Corporation

Trellie Bioinformatics, Inc.

10. 1 out of 28

Ljl Biosystems, Inc.

11. 1 out of 15,475

University of California

Trelolis Bioscience, Inc.

13. 1 out of 165

Molecular Devices Corporation

14. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Respiratory Syncytial Virus

Biofilm Remediation

Cerebral Ischemia

Monoclonal Antibodies

Immune Checkpoint Modulation

Human Cytomegalovirus

Pharmaceutical Composition

Cell-Signaling Assays

Real Time Detection

Insulin Receptor Agonists

Toxicity Assays

Glutathione Analogs

82 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246063 - Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof (2025-03-11),

2. 12152068 - Binding moieties for biofilm remediation (2024-11-26),

3. 12109265 - Drug regimen for treatment of cerebral ischemia (2024-10-08),

4. 11773143 - Conformational epitopes in respiratory syncytial virus G protein central conserved region (2023-10-03),

5. 11725055 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2023-08-15),

6. 11248040 - Binding moieties for biofilm remediation (2022-02-15),

7. 11246928 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2022-02-15),

8. 11077188 - Drug regimen for treatment of cerebral ischemia (2021-08-03),

9. 11046764 - Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 (2021-06-29),

10. 10858431 - Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling (2020-12-08),

11. 10676520 - Antibodies useful in passive influenza immunization (2020-06-09),

12. 10654915 - Antibodies useful in passive influenza immunization (2020-05-19),

13. 10639370 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2020-05-05),

14. 10617756 - Drug regimen for treatment of cerebral ischemia (2020-04-14),

15. 10570193 - Binding moieties for biofilm remediation (2020-02-25),

Title: The Innovative Journey of Lawrence M Kauvar

Introduction: Lawrence M Kauvar, a distinguished inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Lawrence M Kauvar holds several patents in various technological domains, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Lawrence M Kauvar has established himself as a visionary inventor, known for his ability to transform ideas into tangible inventions that have real-world applications.

Collaborations: Throughout his career, Lawrence M Kauvar has collaborated with leading tech companies, research institutions, and universities to further his innovative projects and bring his ideas to fruition.

Conclusion: Lawrence M Kauvar's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…